UMiroliMus
|
- $85 - $2535
- Product name: UMiroliMus
- CAS: 851536-75-9
- MF: C55H87NO14
- MW: 986.28
- EINECS:-0
- MDL Number:MFCD22124433
- Synonyms:BioliMus, BioliMus A9, TRM 986;UMiroliMus;Rapamycin, 42-O-(2-ethoxyethyl)-;BioliMus A9 UMiroliMus;TRM 986;TRM986;TRM-986;Umirolimus (biolimus)
27 prices
Selected condition:
Brand
- aablocks
- AK Scientific
- American Custom Chemicals Corporation
- ApexBio Technology
- AvaChem
- Cayman Chemical
- ChemScene
- TRC
Package
- 1mL(10mMinDMSO)
- 1mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus
- Packaging1mg
- Price$172
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus >98%
- Packaging5mg
- Price$369
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus >98%
- Packaging10mg
- Price$569
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus
- Packaging25mg
- Price$1048
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus >98%
- Packaging50mg
- Price$1647
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00G77B
- Product descriptionUmirolimus >98%
- Packaging100mg
- Price$2535
- Updated2026-05-28
- Buy
- ManufacturerAK Scientific
- Product numberX7251
- Product descriptionUmirolimus
- Packaging5mg
- Price$613
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0007715
- Product descriptionUMIROLIMUS 95.00%
- Packaging5MG
- Price$504
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberBA1298
- Product descriptionUmirolimus
- Packaging10mg
- Price$432
- Updated2026-05-06
- Buy
- ManufacturerApexBio Technology
- Product numberBA1298
- Product descriptionUmirolimus
- Packaging1mL(10mMinDMSO)
- Price$468
- Updated2026-05-06
- Buy
- ManufacturerApexBio Technology
- Product numberBA1298
- Product descriptionUmirolimus
- Packaging5mg
- Price$270
- Updated2026-05-06
- Buy
- ManufacturerApexBio Technology
- Product numberBA1298
- Product descriptionUmirolimus
- Packaging1mg
- Price$122
- Updated2026-05-06
- Buy
- ManufacturerApexBio Technology
- Product numberBA1298
- Product descriptionUmirolimus
- Packaging25mg
- Price$855
- Updated2026-05-06
- Buy
- ManufacturerAvaChem
- Product number4697
- Product descriptionUmirolimus
- Packaging100mg
- Price$1950
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4697
- Product descriptionUmirolimus
- Packaging1mg
- Price$89
- Updated2026-05-22
- Buy
- ManufacturerAvaChem
- Product number4697
- Product descriptionUmirolimus
- Packaging5mg
- Price$269
- Updated2026-05-22
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00G77B | Umirolimus | 1mg | $172 | 2026-05-28 | Buy |
| aablocks | AA00G77B | Umirolimus >98% | 5mg | $369 | 2026-05-28 | Buy |
| aablocks | AA00G77B | Umirolimus >98% | 10mg | $569 | 2026-05-28 | Buy |
| aablocks | AA00G77B | Umirolimus | 25mg | $1048 | 2026-05-28 | Buy |
| aablocks | AA00G77B | Umirolimus >98% | 50mg | $1647 | 2026-05-28 | Buy |
| aablocks | AA00G77B | Umirolimus >98% | 100mg | $2535 | 2026-05-28 | Buy |
| AK Scientific | X7251 | Umirolimus | 5mg | $613 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0007715 | UMIROLIMUS 95.00% | 5MG | $504 | 2021-12-16 | Buy |
| ApexBio Technology | BA1298 | Umirolimus | 10mg | $432 | 2026-05-06 | Buy |
| ApexBio Technology | BA1298 | Umirolimus | 1mL(10mMinDMSO) | $468 | 2026-05-06 | Buy |
| ApexBio Technology | BA1298 | Umirolimus | 5mg | $270 | 2026-05-06 | Buy |
| ApexBio Technology | BA1298 | Umirolimus | 1mg | $122 | 2026-05-06 | Buy |
| ApexBio Technology | BA1298 | Umirolimus | 25mg | $855 | 2026-05-06 | Buy |
| AvaChem | 4697 | Umirolimus | 100mg | $1950 | 2026-05-22 | Buy |
| AvaChem | 4697 | Umirolimus | 1mg | $89 | 2026-05-22 | Buy |
| AvaChem | 4697 | Umirolimus | 5mg | $269 | 2026-05-22 | Buy |
Properties
Boiling point :991.0±75.0 °C(Predicted)
Density :1.15±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
form :A solid
pka :10.40±0.70(Predicted)
color :White to light yellow
Density :1.15±0.1 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: Soluble; DMSO: Soluble; Ethanol: Soluble; Methanol: Soluble
form :A solid
pka :10.40±0.70(Predicted)
color :White to light yellow
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Coronary stents have dramatically improved the success rate of interventional cardiology in recent years, and stent implantation has become the standard of care in percutaneous coronary interventions. However, the long-term success of coronary stenting is hampered by a high rate of restenosis (i.e., recurrence of stenosis, or reblocking), which is caused by proliferation and migration of smooth muscle cells and production of extracellular matrix. The Biomatrix DES is a novel stent system combining a biodegradable PLA and the new anti-restenoic drug biolimus. Biolimus is a semi-synthetic analog of sirolimus wherein the hydroxyl moiety at position 42 is modified to an ethoxyethyl ether group. As with rapamycin, the mechanism of action of biolimus consists of forming a complex with intracellular 12-kDa FK506-binding protein (FKBP-12), which binds to the mammalian target of rapamycin (mTOR) and reversibly inhibits cell-cycle transition of proliferating smooth muscle cells.The antiproliferative potency of biolimus is similar to that of sirolimus; however, it is approximately 10-fold more lipophilic than sirolimus, which results in rapid absorption of the drug into fatty tissues and reduced systemic exposure. The Biomatrixs DES is produced by the absorption of a 1:1 combination of biolimus and PLA on a flexible stainless steel stent. The precision automated coating method used in the production of the stent ensures the PLA biolimus combination is applied solely to the abluminal surface of the stent. PLA is co-released with biolimus over 6 9 months, and biodegraded initially to lactic acid, and eventually to carbon dioxide and water.More related product prices
203911-27-7 SODIUM HYDROSULFIDE HYDRATE Myricetin Xanthophyll Salirasib Doxorubicin hydrochlorideRelated product price
-
203911-27-7
$49-4787.48 -
SODIUM HYDROSULFIDE HYDRATE
$10-5226.64 -
Myricetin
$5-1705
Suppliers and manufacturers
LGM Pharma
Quality Control Solutions Ltd.
Shanghai EFE Biological Technology Co., Ltd.
Lynnchem
Novachemistry
Wuhan FengyaoTonghui Chemical Products Co., Ltd.
Shanghai Hongye Biotechnology Co. Ltd
Shenzhen Polymeri Biochemical Technology Co., Ltd.
Taizhou Crene Biotechnology Co. Ltd.
Shanghai Fuyi Biological Technology Co., Ltd.




